Literature DB >> 20586646

In-hospital death and adverse clinical events in elderly patients according to disease clustering: the REPOSI study.

A Marengoni1, F Bonometti, A Nobili, M Tettamanti, F Salerno, S Corrao, A Iorio, M Marcucci, P M Mannucci.   

Abstract

OBJECTIVE: The aim of the study was to recognize clusters of diseases among hospitalized elderly and to identify groups of patients at risk of in-hospital death and adverse clinical events according to disease clustering.
METHOD: This was a cross-sectional study conducted in 38 internal medicine and geriatric wards in Italy participating in the Registro Politerapie SIMI (REPOSI) study during 2008. The subjects were 1,332 inpatients aged 65 years or older. Clusters of diseases (i.e., two or more co-occurrent diseases) were identified using the odds ratios (OR) for the associations between pairs of conditions, followed by cluster analysis. Logistic regression models were used to evaluate the effect of disease clusters on in-hospital death and adverse clinical events.
RESULTS: A total of 86.7% of the patients were discharged, 8.3% were transferred to another hospital unit, and 5.0% died during hospitalization; 36.4% of the patients had at least one adverse clinical event. Patients affected by the clusters, including heart failure (HF) and either chronic renal failure (CRF) or chronic obstructive pulmonary disease, had a significant association with in-hospital death (OR, 4.3;95% confidence interval [CI], 1.6-11.5; OR, 2.9; 95% CI, 1.1-8.3, respectively), as well as patients affected by CRF and anemia (OR, 6.1; 95% CI, 2.3-16.2). The cluster including HF and CRF was also associated with adverse clinical events (OR, 3.5; 95% CI, 1.5-7.8). The effect of both HF and CRF and anemia and CRF on in-hospital death was additive.
CONCLUSION: Several groups of older patients at risk of in-hospital death and adverse clinical events were identified according to disease clustering. Knowledge of the relationship among co-occurring diseases may help developing strategies to improve clinical practice and preventative interventions.

Entities:  

Mesh:

Year:  2010        PMID: 20586646     DOI: 10.1089/rej.2009.1002

Source DB:  PubMed          Journal:  Rejuvenation Res        ISSN: 1549-1684            Impact factor:   4.663


  18 in total

1.  Do replicable profiles of multimorbidity exist? Systematic review and synthesis.

Authors:  Ljoudmila Busija; Karen Lim; Cassandra Szoeke; Kerrie M Sanders; Marita P McCabe
Journal:  Eur J Epidemiol       Date:  2019-10-17       Impact factor: 8.082

Review 2.  Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register.

Authors:  Pier Mannuccio Mannucci; Alessandro Nobili; Luca Pasina
Journal:  Intern Emerg Med       Date:  2018-08-31       Impact factor: 3.397

3.  Predicting hospital readmissions in older patients with heart failure with advanced bioinformatics tools: focus on the role of vulnerability and frailty.

Authors:  Marco Bertolotti; Carlotta Franchi; Giulia Lancellotti; Sara Mandelli; Chiara Mussi
Journal:  Intern Emerg Med       Date:  2022-09-23       Impact factor: 5.472

Review 4.  Multimorbidity and polypharmacy in the elderly: lessons from REPOSI.

Authors:  Pier Mannuccio Mannucci; Alessandro Nobili
Journal:  Intern Emerg Med       Date:  2014-08-28       Impact factor: 3.397

5.  A Study on Polypharmacy and Potential Drug-Drug Interactions among Elderly Patients Admitted in Department of Medicine of a Tertiary Care Hospital in Puducherry.

Authors:  Kartik Janardan Salwe; Dharani Kalyansundaram; Yogesh Bahurupi
Journal:  J Clin Diagn Res       Date:  2016-02-01

Review 6.  Aging and Multimorbidity: New Tasks, Priorities, and Frontiers for Integrated Gerontological and Clinical Research.

Authors:  Elisa Fabbri; Marco Zoli; Marta Gonzalez-Freire; Marcel E Salive; Stephanie A Studenski; Luigi Ferrucci
Journal:  J Am Med Dir Assoc       Date:  2015-05-07       Impact factor: 4.669

Review 7.  Multiple diseases and polypharmacy in the elderly: challenges for the internist of the third millennium.

Authors:  Alessandro Nobili; Silvio Garattini; Pier Mannuccio Mannucci
Journal:  J Comorb       Date:  2011-12-27

8.  The complexity of patients hospitalized in Internal Medicine wards evaluated by FADOI-COMPLIMED score(s). A hypothetical approach.

Authors:  Erminio Bonizzoni; Gualberto Gussoni; Giancarlo Agnelli; Raffaele Antonelli Incalzi; Moira Bonfanti; Franco Mastroianni; Marco Candela; Carlotta Franchi; Stefania Frasson; Antonio Greco; Micaela La Regina; Roberta Re; Giorgio Vescovo; Mauro Campanini
Journal:  PLoS One       Date:  2018-04-16       Impact factor: 3.240

9.  Global Multimorbidity Patterns: A Cross-Sectional, Population-Based, Multi-Country Study.

Authors:  Noe Garin; Ai Koyanagi; Somnath Chatterji; Stefanos Tyrovolas; Beatriz Olaya; Matilde Leonardi; Elvira Lara; Seppo Koskinen; Beata Tobiasz-Adamczyk; Jose Luis Ayuso-Mateos; Josep Maria Haro
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-09-29       Impact factor: 6.053

10.  Deconstructing Complex Multimorbidity in the Very Old: Findings from the Newcastle 85+ Study.

Authors:  Joanna Collerton; Carol Jagger; Mohammad E Yadegarfar; Karen Davies; Stuart G Parker; Louise Robinson; Thomas B L Kirkwood
Journal:  Biomed Res Int       Date:  2016-01-13       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.